Scientists Discover ‘Protein Neighborhood’ Key to Cellular Signaling and Drug Resistance
Table of Contents
A newly discovered protein network offers a novel approach to regulating cellular signaling and potentially overcoming drug resistance, according to research published December 5, 2025, in Nature Communications. The study, conducted by scientists at St. Jude Children’s Research Hospital, sheds light on how cells maintain precise control over vital signaling pathways.
Understanding cAMP and the Role of ABCC4
When a cell receives a message from its environment, it relies on a molecule called cyclic AMP (cAMP) to relay that information internally. Maintaining appropriate cAMP levels is crucial for ensuring signals reach the correct targets without triggering unintended consequences. The ABCC4 protein plays a key role in this process, transporting cAMP out of cells and also contributing to resistance against certain drugs. However, the mechanism by which ABCC4 is positioned and stabilized to perform these functions remained a mystery.
A ‘Neighborhood’ Effect Stabilizes ABCC4
Researchers found that elevating cAMP levels globally promotes ABCC4’s movement to the cell membrane and stabilizes the protein, effectively creating a “protein neighborhood” that anchors it in place. This localized concentration of ABCC4 is essential for regulating cAMP signaling. A key component of this neighborhood was identified as SCRIB, a protein that interacts directly with ABCC4.
“We examined ABCC4 with an inhibitor, Ceefourin-2, and noticed something strange: At concentrations that should completely inhibit the protein’s activity, we couldn’t see any demonstrable stabilization,” a senior researcher explained. “So, we wondered if it’s actually affecting a network of proteins and explored both close and distant interactions.”
PDZ Motifs Act as ‘Sticky Tape’ for Protein Interactions
The team discovered that interactions between ABCC4 and neighboring proteins, facilitated by structures called PDZ motifs, are critical for maintaining ABCC4’s position at the cell membrane. These PDZ motifs act like “sticky tape,” binding to other proteins containing PDZ domains and restricting ABCC4’s movement. Disrupting these interactions destabilizes ABCC4 and impairs cAMP transport.
Further investigation revealed that a known ABCC4 inhibitor disrupts the interaction between ABCC4 and SCRIB, the most significant member of this protein network. This disruption causes ABCC4 to diffuse throughout the cell, diluting the cAMP signaling effect.
Implications for Future Therapies
These findings offer a new avenue for regulating ABC transporters – a vital class of proteins involved in numerous cellular processes – by targeting not just the active site of the protein itself, but also the surrounding membrane environment. The ability to modulate these protein networks could open up new therapeutic opportunities for modifying cAMP signaling and overcoming drug resistance.
“This work implies SCRIB is the most important, but there could be others,” the lead researcher stated. “This demonstrates that many transport proteins aren’t isolated — they’re connected to a network.”
Study Details and Funding
The study was led by John Schuetz, PhD, of the St. Jude Department of Pharmacy & Pharmaceutical Sciences, and involved contributions from Jingwen Zhu and Sabina Ranjit as first authors. Additional authors included Anjaparavanda Naren (Cedars-Sinai Medical Center) and Tomoka Gose, Amanda Nourse, Vishwajeeth Pagala, Zuo-Fei Yuan, John Lynch, Yao Wang, Aaron Pitre, Rebecca Crawford, Junmin Peng, and Juwina Wijaya (St. Jude).
The research was supported by grants from the National Institutes of Health (R01 CA194057, CA194206, P30 CA21745, CA21865, 5R01DK080834, P30 CA021765, and CA96832) and the American Lebanese Syrian Associated Charities (ALSAC), the fundraising and awareness organization of St. Jude.
